Latest Webinars, eBooks, & Podcasts

Latest Commentary

Magazine

In this issue of GEN, read how CRISPR components can be engineered into antibacterial agents. Also, small-molecule therapeutic research takes aim at disrupting cancer using a machine-learning drug discovery approach. Find out the liquid biopsy technique is making progress in its usefulness as a cancer diagnostic. And check out our latest A List: The Unlucky 13 of 2018: Phase III clinical trial failures with dire consequences for companies.

Recently Featured

Stay Connected

557,147FansLike
46,468FollowersFollow
Scroll Up